[PLX] QoQ Quarter Result on 31-Dec-2015 [#Q4]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
08-Mar-2016
Financial Year
2015
Quarter
31-Dec-2015 [#Q4]
Profit Trend
QoQ- 2,008.38%
YoY- 960.79%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 CAGR
Revenue 4,670 1,769 679 -11,195 5,846 4,616 5,097 -5.65%
PBT -7,290 -10,736 -8,526 -12,419 -3,820 -5,071 -5,972 14.17%
Tax 268 213 314 -85,260 17 43 28 348.94%
NP -7,290 -10,853 -8,598 72,900 -3,820 -5,071 -5,972 14.17%
Tax Rate - - - - - - - -
Total Cost 11,960 12,622 9,277 -84,095 9,666 9,687 11,069 5.28%
Ratio Analysis
30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 CAGR
NP Margin -156.10 -613.51 -1,266.27 -651.18 -65.34 -109.86 -117.17 21.01%
Per Share
30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 CAGR
EPS -0.07 -0.11 -0.09 7.31 -0.04 -0.05 -0.06 10.79%
EPS Diluted -0.07 -0.11 -0.09 7.31 -0.04 -0.05 -0.06 10.79%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.